Showing results (331-340 of 351) with videos related to
Sort By:
Pageof 36
Journal of Virology|February 14, 2003
Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapyMark Dybul, Marybeth Daucher, Mark A Jensen, et al.Cancer Research|February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimersRitwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.Annals of Internal Medicine|July 3, 2002
High prevalence of osteonecrosis of the femoral head in HIV-infected adultsKirk D Miller, Henry Masur, Elizabeth C Jones, et al.Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.Oncotarget|January 22, 2015
Functional consequence of the MET-T1010I polymorphism in breast cancerShuying Liu, Funda Meric-Bernstam, Napa Parinyanitikul, et al.Emerging Microbes & Infections|February 8, 2021
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaquesYuzhong Li, Yanwei Bi, Hongjian Xiao, et al.Nature Biotechnology|November 4, 2024
Binary vector copy number engineering improves Agrobacterium-mediated transformationMatthew J Szarzanowicz, Lucas M Waldburger, Michael Busche, et al.Journal of the National Cancer Institute|February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancerAna M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.Science Advances|April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicineLorenzo Federico, Zechen Chong, Dong Zhang, et al.Research Square|October 27, 2023
Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV StrainsShixia Wang, Kun-Wei Chan, Danlan Wei, et al.Pageof 36